跳轉至內容
Merck

[A heart without overspeed trip unit].

Praxis (2014-04-24)
Roman Gähwiler, Christian Templin, Thomas F Lüscher, Jelena-Rima Ghadri
摘要

We report the case of a 38-year patient who presented in our outpatient clinic for cardiac evaluation and assessment as volunteer firefighter. The patient had an asymptomatic sinustachycardia, which was diagnosed at the age of 15. After we excluded secondary etiologies, as well as a postural orthostatic tachycardia syndrome (POTS) diagnosis of inappropriate sinus tachycardia (IST) was confirmed. A metoprolol therapy was established, however to resistant tachycardia, we suggested a combined therapy of Bisoprolol and Ivabradin, which resulted successfully in normocard sinus rhythm.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
美托洛尔 (+)-酒石酸盐, ≥98% (titration), powder
USP
比索洛尔 半富马酸盐, United States Pharmacopeia (USP) Reference Standard
USP
美托洛尔 (+)-酒石酸盐, United States Pharmacopeia (USP) Reference Standard
Supelco
美托洛尔 (+)-酒石酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
美托洛尔 酒石酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
比索洛尔 半富马酸盐, ≥98% (HPLC), solid
比索洛尔 半富马酸盐, European Pharmacopoeia (EP) Reference Standard
美托洛尔 (+)-酒石酸盐, European Pharmacopoeia (EP) Reference Standard
比索洛尔 半富马酸盐, European Pharmacopoeia (EP) Reference Standard